Wasan H. The emerging synergy between radioembolisation, systemic chemotherapy and liver surgery in metastatic colorectal cancer. European Oncological Disease 2007; 1: 54–58.

Gulec SA, Fong Y. Yttrium 90 microsphere selective internal radiation treatment of hepatic colorectal metastases. Arch Surg 2007; 142: 675–682.

Khatria VP, Cheeb KG, Petrellic NJ. Modern multimodality approach to hepatic colorectal metastases: Solutions and controversies. Surgical Oncology 2007; Epub: doi:10.1016/j.suronc.2007.05.001.

Ryan D. Nonsurgical approaches to colorectal cancer. The Oncologist 2006; 11: 999–1002.

Welsh JS, Kennedy AS, Thomadsen B. Selective internal radiation therapy (SIRT) for liver metastases secondary to colorectal adenocarcinoma. International Journal of Radiation Oncology, Biology and Physics 2006; 66 (2 Suppl. S): S62–S73.

Morris D. Selective internal radiation therapy with ⁹⁰ Y-microspheres for colorectal liver metastases: cart before the horse or otherwise? ANZ Journal of Surgery 2006; 76: 675.

Hendlisz A, Personeni N, Delaunoit T et al. Hepatic intra-arterial injection of yttrium-loaded microspheres for liver metastasis secondary to colorectal cancer: best soups are sometimes made from old recipies. Acta Gastroenterologica Belgica 2006; 69: 55–58.

Liu L, Zhang W, Jiang H. Current treatment for liver metastases from colorectal cancer. World Journal of Gastroenterology 2003; 9: 193–200.

Avila MA, Berasain C, Sangro B, Prieto J. New therapies for hepatocellular carcinoma. Oncogene 2006; 25 (27): 3866–3884.

Clark H, Carson W, Kavanagh P et al. Staging and current treatment of hepatocellular carcinoma. Radiographics 2005; 25: S3–S23.

Lambert B, Van de Wiele C. Treatment of hepatocellular carcinoma by means of radiopharmaceuticals. European Journal of Nuclear Medicine and Molecular Imaging 2005; 32: 980–989.

Ho S, Johnson P, Leung W et al. Combating hepatocellular carcinoma with an integrated approach. Chinese Medical Journal 1998; 112: 80–83.

Ngan H. Imaging and radiological intervention in hepatocellular carcinoma. Hong Kong Medical Journal 1997; 3: 57–68.

Falconi M, Plockinger U, Kwekkeboom DJ et al. Well-differentiated pancreatic nonfunctioning tumors/ carcinoma. Neuroendocrinology 2006; 84: 196–211.

Madoff D, Gupta S, Ahrar K et al. Update on the management of neuroendocrine hepatic metastases. Journal of Vascular and Interventional Radiology 2006; 17: 1235–1250.

Plockinger U, Rindi G, Arnold R et al. Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS). Neuroendocrinology 2004; 80: 394–424.

Jakobs TF, Hoffmann RT, Tatsch K et al. Developments and perspectives in radioablative techniques. Radiologe 2007 Dec; 47: 1083–1088.

Brown DB, Gould JE, Gervais DA et al. Transcatheter therapy for hepatic malignancy: Standardization of terminology and reporting criteria. Journal of Vascular and Interventional Radiology 2007; 18: 1469–1478.

Bilbao JI, Martínez-Cuesta A, Alonso A, Rodríguez J, Arbizu J, Sangro B. Radioembolization with Yttrium-90. Cardiovascular and Interventional Radiology 2007; Abs. 1503.2.

Gates VL, Atassi B, Lewandowski RJ et al. Radioembolization with yttrium-90 microspheres: review of an emerging treatment for liver tumors. Future Oncology February 2007; 3: 73–81.

Lewandowski RJ, Salem R. Yttrium-90 radioembolization of hepatocellular carcinoma and metastatic disease to the liver. Seminars in Interventional Radiology 2006; 23 (1): 64–72.

Salem R, Thurston K. Radioembolization with ⁹⁰ yttrium microspheres: A state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 3: Comprehensive literature review and future direction. Journal of Vascular and Interventional Radiology 2006; 17: 1571–1594.

Salem R, Thurston K. Radioembolization with ⁹⁰ yttrium microspheres: A state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 2: Special topics. Journal of Vascular and Interventional Radiology 2006; 17: 1425–1439.

Salem R, Thurston K. Radioembolization with ⁹⁰ yttrium microspheres: A state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: Technical and methodologic considerations. Journal of Vascular and Interventional Radiology 2006; 17: 1251–1278.

Brans B, Linden O, Giammarile F et al. Clinical applications of newer radionuclide therapies. European Journal of Cancer 2006; 42: 994–1003.

Murthy R, Habbu A, Salem R. Trans-arterial hepatic radioembolisation of yttrium-90 microspheres. Biomedical Imaging and Intervention Journal 2006; 2 (3): e43

Kennedy A, Coldwell D, Liu D et al. Liver directed radiotherapy with microspheres: second annual clinical symposium. American Journal of Oncology Review 2006; 4: 1–8.

Garrean S, Espat N. Yttrium-90 internal radiation therapy for hepatic malignancy. Surgical Oncology 2005; 14: 179–193.

Coldwell D, Sewell P. The expanding role of interventional radiology in the supportive care of the oncology patient: From diagnosis to therapy. Seminars in Oncology 2005; 32: 169–173.

Sinha VR, Goyel V, Trehan A. Radioactive microspheres in therapeutics. Pharmazie 2004; 59: 419–426.

Bronson J. The malignant liver: Community-based state-of-the-art therapy. Imaging Economics 2004; 17: 25–30.

Moroz P, Gray B. Radiotherapy in the treatment of advanced liver cancer: current status and future directions. Asian Journal of Surgery 2000; 23: 32–41.

Ho S, Lau W, Leung T et al. Internal radiation therapy for patients with primary or metastatic hepatic cancer. Cancer 1998; 83: 1894–1907.